Published Date: 13 Sep 2024
Add-on ADC, monoclonal antibody consistently increase pCR versus PD-1 inhibitor plus chemotherapy
Read Full NewsA trial tests whether 40Gy in 15 fractions over 3 weeks leads to more arm lymphedema than 50Gy in 25 fractions over 5 weeks.
State mandates requiring insurance coverage for additional breast cancer scans for those with dense breasts are failing to boost usage.
1.
Q&A: Odds of surviving cancer drop drastically when credit score dips
2.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
3.
Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.
4.
Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer
5.
Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer
1.
Cancer Evolution and Therapeutic Resistance: Mechanisms, Clinical Insights, and Emerging Strategies
2.
An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025
3.
Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology
4.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
5.
Evidence-Based Insights in Oncology for Specialists
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
2.
Navigating the Complexities of Ph Negative ALL - Part XI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation